Technology | September 27, 2011

AF Stat Releases Smartphone App Upgrade

September 27, 2011 — AF Stat released updates to the AFib Educator, a free smartphone app and desktop widget designed to help healthcare providers better explain atrial fibrillation (AFib) to their patients.

AFib is the most common form of irregular heartbeat, affecting an estimated 2.5 million Americans. This figure could increase to 12 million by 2050. A complex and poorly understood disease, AFib is associated with reduced quality of life; it also worsens other heart diseases and increases risk for stroke, hospitalization and death.

The AFib Educator 2.0 visually demonstrates the importance of management strategies defined in the American Heart Association (AHA), American College of Cardiology (ACC) and Heart Rhythm Society (HRS) AFib clinical treatment guidelines; these strategies include rate control, rhythm control, and stroke prevention.

"The first-generation AFib Educator has proven to be a very effective tool for helping explain to patients what happens to the heart during AFib," said Eric Prystowsky, M.D., director of the clinical electrophysiology laboratory at St. Vincent Indianapolis Hospital and AF Stat's medical chair. "The updated app helps physicians extend that discussion to illustrate how the heart may respond to different management strategies, and the risks patients may face from not comprehensively managing the disease."  

New animations show patients important potential consequences of AFib, including stroke risk and heart remodeling. One animation shows how a blood clot can form and flow to the brain, causing an AFib-related stroke; another illustrates heart remodeling, in which the heart changes size and shape as a result of being in AFib over time.

"Atrial remodeling during persistent AFib is not a well-appreciated consequence of AFib," said Prystowsky.  "Many patients do not realize that the structural changes in their atria may prevent restoration of sinus rhythm, and the loss of atrial contribution to cardiac output may result in substantial adverse symptoms to the patient. Physicians need sophisticated tools to demonstrate the complexity of potential risks of AFib and the need for a comprehensive management strategy.  The AFib Educator 2.0 is designed to help meet that need."

The upgrade also includes popular features from the original application, including important patient resources about the signs, symptoms and prevalence of AFib; links to resources where patients can learn more about the disease; and an "e-mail a friend" feature, which allows healthcare professionals to e-mail background information directly to patients.  

Since the original version was released in 2010, the AFib Educator has been downloaded more than 13,000 times, and continues to receive positive reviews.

The app and desktop widget are available for free download at AF Stat’s website. The app can also be downloaded from the Apple App Store online.

For more information: www.afstat.com

Related Content

HRS study finds Frequent Coffee Consumption Lowers Chance of Arrhythmias. #HRS #HRS20 Heartrhythm20
News | EP Lab | May 28, 2020
May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater ri
he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

he Actus AcQMap EP 3-D mapping catheter used  to speed  electromapping and procedure times.

News | EP Lab | May 20, 2020
May 20, 2020 — Acutus Medical and Biotronik announced a new alliance to provide a comprehensive portfolio of...
Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate catheter.
News | EP Lab | May 19, 2020
May 19, 2020 – Thermedical, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), an
HRS presentations included BlueSync Evaluation study for Medtronic MyCareLink Heart mobile app and Micra TPS CED Study
News | EP Lab | May 14, 2020
May 14, 2020 – Medtronic announced results from late-breaking clinical trials evaluating the MyCareLink Heart mobile
Etripamil Nasal Spray Does Not Meet Primary Endpoint in Treating Supraventricular Tachycardia in the NODE-301 trial presented at Heart Rhythm 2020. #heartrhythm2020 #HRS2020
News | EP Lab | May 13, 2020
May 13, 2020 — The patient-administered nasal spray drug etripamil did not meet its primary endpoint in treating pati
Medtronic Cobalt and Crome ICD
News | EP Lab | May 12, 2020
May 12, 2020 — Medtronic has received U.S.
The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time. FDA clears, approved, the HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation.

The CardioFocus HeartLight Excalibur Balloon X3 ablation system allows direct visualization of the laser ablation procedure, helping reduce use of X-ray angiography and reducing procedure time.

News | EP Lab | May 12, 2020
May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc.
EP lab photo from Philips Healthcare
News | EP Lab | April 30, 2020
May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to edu
The European Heart Rhythm Association (EHRA) electrophysiology (EP) annual meeting cancelled due to coronavirus. #COVID19 #coronavirus #2019nCoV
Feature | EP Lab | March 10, 2020 | Dave Fornell, Editor
March 10, 2020 — Novel coronavirus (...
The U.S. Food and Drug Administration (FDA) cleared the Acutus Medical SuperMap, an addition to its AcQMap 3-D imaging and mapping system used to guide electrophysiology (EP) catheter ablation procedures. Adding the SuperMap mode to the AcQMap system enables users to visualize any atrial rhythm in less than three minutes. Rapidly mapping and re-mapping the whole heart chamber facilitates a new procedural workflow in EP ablation, making it practical to execute an iterative "map, ablate, re-map" approach.
News | EP Lab | March 05, 2020
March 5, 2020 — The U.S.